| Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes Y Okada, B Han, LC Tsoi, PE Stuart, E Ellinghaus, T Tejasvi, V Chandran, ... The American Journal of Human Genetics 95 (2), 162-172, 2014 | 248 | 2014 |
| Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity L Eder, J Jayakar, R Pollock, F Pellett, A Thavaneswaran, V Chandran, ... Annals of the rheumatic diseases 72 (12), 1956-1961, 2013 | 138 | 2013 |
| Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae DR Pillai, D Shahinas, A Buzina, RA Pollock, R Lau, K Khairnar, A Wong, ... BMC genomics 10, 1-13, 2009 | 134 | 2009 |
| Epigenetics of psoriatic disease: a systematic review and critical appraisal RA Pollock, F Abji, DD Gladman Journal of autoimmunity 78, 29-38, 2017 | 94 | 2017 |
| Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis F Abji, RA Pollock, K Liang, V Chandran, DD Gladman Arthritis & Rheumatology 68 (12), 2911-2916, 2016 | 93 | 2016 |
| IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients L Eder, V Chandran, F Pellett, R Pollock, S Shanmugarajah, CF Rosen, ... Annals of the rheumatic diseases 70 (9), 1594-1598, 2011 | 85 | 2011 |
| Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis V Chandran, SB Bull, FJ Pellett, R Ayearst, RA Pollock, DD Gladman Rheumatology 53 (2), 233-239, 2014 | 71 | 2014 |
| Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis V Chandran, H Shen, RA Pollock, FJ Pellett, A Carty, RJ Cook, ... The Journal of Rheumatology 40 (6), 866-871, 2013 | 62 | 2013 |
| Gene expression differences between psoriasis patients with and without inflammatory arthritis RA Pollock, F Abji, K Liang, V Chandran, FJ Pellett, C Virtanen, ... The Journal of investigative dermatology 135 (2), 620-623, 2015 | 48 | 2015 |
| Differential major histocompatibility complex class I chain‐related A allele associations with skin and joint manifestations of psoriatic disease R Pollock, V Chandran, J Barrett, L Eder, F Pellett, C Yao, M Lino, ... Tissue antigens 77 (6), 554-561, 2011 | 47 | 2011 |
| Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis A Muntyanu, F Abji, K Liang, RA Pollock, V Chandran, DD Gladman Arthritis research & therapy 18, 1-10, 2016 | 45 | 2016 |
| The functional MICA‐129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA‐B and HLA‐C RA Pollock, V Chandran, FJ Pellett, A Thavaneswaran, L Eder, J Barrett, ... Tissue Antigens 82 (1), 43-47, 2013 | 42 | 2013 |
| Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis RA Pollock, L Zaman, V Chandran, DD Gladman PLoS One 14 (2), e0212043, 2019 | 28 | 2019 |
| Further evidence supporting a parent‐of‐origin effect in psoriatic disease RA Pollock, A Thavaneswaran, F Pellett, V Chandran, A Petronis, ... Arthritis Care & Research 67 (11), 1586-1590, 2015 | 28 | 2015 |
| Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis F Abji, RA Pollock, K Liang, V Chandran, DD Gladman Clin Exp Rheumatol 36 (3), 486-9, 2018 | 19 | 2018 |
| Association of variably expressed KIR3dl1 alleles with psoriatic disease J Berinstein, R Pollock, F Pellett, A Thavaneswaran, V Chandran, ... Clinical rheumatology 36, 2261-2266, 2017 | 19 | 2017 |
| Declining levels of serum chemokine (C‐X‐C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker? F Abji, KA Lee, RA Pollock, R Machhar, RJ Cook, V Chandran, ... British Journal of Dermatology 183 (5), 920-927, 2020 | 18 | 2020 |
| Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension L Eder, DD Gladman, P Mease, RA Pollock, R Luna, SZ Aydin, A Ogdie, ... RMD open 9 (1), e002718, 2023 | 14 | 2023 |
| AB0160 epigenetic studies in maternally versus paternally transmitted psoriatic disease DD O'Rielly, R Pollock, Y Zhang, N Al-Ghanim, R Yazdani, S Hamilton, ... Annals of the Rheumatic Diseases 73, 856, 2014 | 9 | 2014 |
| Exploring cannabis use and perspectives among psoriatic disease patients J Tsang, O Silverberg, R Machhar, R Pollock, D Pereira, M Sutton, ... Clinical Rheumatology 41 (5), 1431-1437, 2022 | 7 | 2022 |